MX2007015672A - Liberacion controlada de un farmaco a traves de la piel sobre la base de una composicion topica que comprende el farmaco, una silicona formadora de pelicula y al menos un solvente volatil. - Google Patents

Liberacion controlada de un farmaco a traves de la piel sobre la base de una composicion topica que comprende el farmaco, una silicona formadora de pelicula y al menos un solvente volatil.

Info

Publication number
MX2007015672A
MX2007015672A MX2007015672A MX2007015672A MX2007015672A MX 2007015672 A MX2007015672 A MX 2007015672A MX 2007015672 A MX2007015672 A MX 2007015672A MX 2007015672 A MX2007015672 A MX 2007015672A MX 2007015672 A MX2007015672 A MX 2007015672A
Authority
MX
Mexico
Prior art keywords
drug
accor
composition
vitamin
method accor
Prior art date
Application number
MX2007015672A
Other languages
English (en)
Spanish (es)
Inventor
Claire Mallard
Philippe Andres
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of MX2007015672A publication Critical patent/MX2007015672A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2007015672A 2005-06-10 2006-05-22 Liberacion controlada de un farmaco a traves de la piel sobre la base de una composicion topica que comprende el farmaco, una silicona formadora de pelicula y al menos un solvente volatil. MX2007015672A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68928205P 2005-06-10 2005-06-10
PCT/EP2006/005831 WO2006131401A2 (en) 2005-06-10 2006-05-22 Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent

Publications (1)

Publication Number Publication Date
MX2007015672A true MX2007015672A (es) 2008-02-20

Family

ID=37137556

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007015672A MX2007015672A (es) 2005-06-10 2006-05-22 Liberacion controlada de un farmaco a traves de la piel sobre la base de una composicion topica que comprende el farmaco, una silicona formadora de pelicula y al menos un solvente volatil.

Country Status (11)

Country Link
EP (1) EP1901709A2 (pt)
JP (1) JP2008542423A (pt)
KR (1) KR20080016612A (pt)
CN (1) CN101247787B (pt)
AR (1) AR054381A1 (pt)
AU (1) AU2006256860B2 (pt)
BR (1) BRPI0613230A2 (pt)
CA (1) CA2610755A1 (pt)
MX (1) MX2007015672A (pt)
RU (1) RU2008100037A (pt)
WO (1) WO2006131401A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
MX2009009557A (es) * 2007-03-08 2010-08-10 Crescendo Therapeutics Llc Formulaciones de aposito para prevenir o reducir la cicatrizacion.
EP2167036B1 (en) * 2007-07-11 2013-09-18 Dow Corning Corporation Compositions for delivering a drug
BR112012001098A2 (pt) * 2009-07-09 2015-09-01 Crescendo Therapeutics Llc Método de cicatrização de feridas e modulação de cicatriz
US9254296B2 (en) 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
AU2009357263B2 (en) * 2009-12-22 2015-04-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
US20160095876A1 (en) 2014-10-01 2016-04-07 Rochal Industries, Llp Composition and kits for inhibition of pathogenic microbial infection and methods of using the same
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
KR20190026397A (ko) 2017-09-05 2019-03-13 안준배 노이즈 필터링 장치 및 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
JP3251717B2 (ja) * 1992-06-29 2002-01-28 花王株式会社 皮膚外用剤
JP3573803B2 (ja) * 1994-02-16 2004-10-06 ポーラ化成工業株式会社 皮膚外用剤
BR9708081A (pt) * 1996-03-16 1999-07-27 Hoechst Ag Formulações tópicas para tratamento de psóriase de unhas
GB9902812D0 (en) * 1998-06-18 1999-03-31 Dow Corning Sa Composition for delivering pharmaceutically active agents
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
WO2000072817A1 (en) * 1999-05-28 2000-12-07 Neutrogena Corporation Water-in-oil emulsion comprising a silicone gel containing vitamin c
US6365670B1 (en) * 2000-03-10 2002-04-02 Wacker Silicones Corporation Organopolysiloxane gels for use in cosmetics
DE10019128A1 (de) * 2000-04-18 2001-11-15 Wella Ag Aerosolschaum zur Haarbehandlung
US6410038B1 (en) * 2000-06-14 2002-06-25 Dow Corning Corporation Water-in-oil-in-polar solvent emulsions
PL212660B1 (pl) * 2000-10-27 2012-11-30 Leo Pharma As Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie
JP2004189639A (ja) * 2002-12-09 2004-07-08 Pola Chem Ind Inc 乳化組成物
US20040228821A1 (en) * 2003-05-16 2004-11-18 The Procter & Gamble Company Personal care products comprising active agents in a gel network
WO2005053666A1 (en) * 2003-11-21 2005-06-16 Galderma Research & Development, S.N.C. Sprayable composition for the administration of vitamin d derivatives
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile

Also Published As

Publication number Publication date
AU2006256860A1 (en) 2006-12-14
JP2008542423A (ja) 2008-11-27
AU2006256860B2 (en) 2012-04-19
RU2008100037A (ru) 2009-07-20
BRPI0613230A2 (pt) 2011-01-04
WO2006131401A2 (en) 2006-12-14
CN101247787A (zh) 2008-08-20
WO2006131401A3 (en) 2007-03-15
EP1901709A2 (en) 2008-03-26
AR054381A1 (es) 2007-06-20
CN101247787B (zh) 2011-10-05
KR20080016612A (ko) 2008-02-21
CA2610755A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
AU2006256860B2 (en) Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
MXPA06014300A (es) Composicion para el tratamiento de psoriasis que comprende un agente siliconado, un corticosteroide y vitamina d o un derivado del mismo.
US20070135379A1 (en) Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
WO2005123092A1 (en) Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
ES2322269T3 (es) Composiciones en forma de spray que contiene un principio activo farmaceutico, al menos una silicona volatil y una fase oleosa no volatil.
US9415002B2 (en) Polysilicone base for scar treatment
US20100216753A1 (en) Controlled release of drugs into/through the skin
US20080194528A1 (en) Pharmaceutical compositions comprising organopolysiloxane elastomers and solubilized bioactive compounds
JP2012530719A (ja) 瘢痕治療用シリコーン製剤
JP2015530383A (ja) 化粧用又は皮膚科用組成物
JP7069176B2 (ja) 医薬組成物
US20220273671A1 (en) Topical formulations for treatment of peripheral neuropathies
ITUB20153889A1 (it) Gel idrofobico a base di vitamina E esente da prodotti siliconici per applicazione topica
BRPI0701215A2 (pt) creme hidratante (emulsão cosmética) contendo óleo de sementes de guariroba (syagrus oleracea becc.)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal